Scott Uknes is co-founder and co-CEO of AgBiome, a company focused on traits and biologicals for agriculture. Previously, Scott served as the Global Lead in the In and Out Licensing function for Bayer Cropscience Bioscience based in Monheim Germany and Ghent Belgium. Prior to the acquisition by Bayer, Scott was the Vice President of Business Development for Athenix. Scott was also a co-founder of Cropsolution, and before that a co-founder of Paradigm Genetics where he was member of the team that designed and presented the IPO of Paradigm Genetics. Before starting Paradigm Genetics, Inc., he managed the scientific effort aimed at understanding the mode-of-action of a novel class of disease control compounds called “plant activators” at Novartis (now Syngenta; Bion® and Actigard®). Dr. Uknes received his Ph. D. in Plant Molecular Biology from Washington University in St. Louis with Dr. David Ho and his B.S. in Honors Biology from the University of Illinois. Dr. Uknes has authored more than 40 scholarly works, is an inventor on more than 20 patents or patent applications, helped negotiate $450 million in R and D deals and has helped raise more than $500 million in public and private equity capital.